PixarBio (OTC:PXRB) faces its own legal problems: a possible lawsuit by the SEC, legal action by a disgruntled employee who is demanding unpaid wages and former landlords looking for $1.8 million in unpaid rent.
But the 7-person biotech is also looking to launch some litigation of its own, according to a recent document it filed with the SEC – PixarBio plans to sue InVivo Therapeutics (NSDQ:NVIV) for libel and for the patent rights to the company’s scaffold device.
Get the full story at our sister site, Drug Delivery Business News.
The post Facing legal woes, PixarBio takes aim at InVivo appeared first on MassDevice.